All Cancer is a curse
At the ESMO - European Society for Medical Oncology 2024 conference this weekend, lots of innovative work will be presented that will help us all take the next set of steps to break this curse of cancer.
For e.g. there are over 208 posters and presentations related to Non Small Cell Lung Cancer (NSCLC). If I asked you a question like "Identify articles and studies describing efficacy and outcomes using immune check point based therapies for non small cell lung cancer. Share key drugs being reported and summarize their efficacy. include data where available", based on just PubMed, how quickly can you answer it?
Here's an image of the illustrative output from our Knolens InsightsMiner solution. 2 clicks. 30 seconds. Full source attribution.
As a professional in this field, are you able to rapidly analyze the multi-dimensional impacts? As a company, can you quickly assess and make decisions on the impact such developments will have for your market access and product development processes?
Reach out to me if you want to have a discussion around how you can accelerate your analysis and decision making processes for new product development, market access, HEOR, HTA and competitive intelligence functions.
#AllCancerIsACurse #knolens #pienomial